Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             293 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aims & Scope/Editorial Board 2012
 2 3 p. IFC-
1 p.
 artikel
2 General Information 2012
 2 3 p. iv-v
nvt p.
 artikel
3 ISSHP Author Index 2012
 2 3 p. I-VII
nvt p.
 artikel
4 ISSHP Session Index 2012
 2 3 p. vi-
1 p.
 artikel
5 OS058. Aldosterone deficiency adversely affects pregnancy outcome in mice Todkar, A.
 2012
 2 3 p. 208-
1 p.
 artikel
6 OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency Molvarec, A.
 2012
 2 3 p. 177-
1 p.
 artikel
7 OS056. Angiotensin II sensitivity and endothelial dysfunction afterexperimental preeclampsia der Graaf van, A.M.
 2012
 2 3 p. 207-
1 p.
 artikel
8 OS041. Apolipoprotein A-I protects normal integration of the trophoblast into endothelial cellular networks in an in vitro model of preeclampsia Charlton, F.
 2012
 2 3 p. 198-199
2 p.
 artikel
9 OS104. Are preeclampsia and adverse obstetrical outcomes predictors for longterm cardiovascular disease? Sia, W.W.
 2012
 2 3 p. 236-
1 p.
 artikel
10 OS059. Blockade of the bradykinin B2 receptor in early pregnancy reduces fetal growth and trophoblast invasion in guinea-pigs Valdes, G.
 2012
 2 3 p. 208-209
2 p.
 artikel
11 OS035. Blood pressure measurement by health professionals, comparison with American Heart Association Technique Sahbaeiroy, F.
 2012
 2 3 p. 194-195
2 p.
 artikel
12 OS074. Brachial artery flow-mediated dilatation as a predictor of pre-eclampsia in the first trimester of pregnancy Alves, J.A. Gurgel
 2012
 2 3 p. 217-218
2 p.
 artikel
13 OS024. Characteristics and outcomes of critically ill obstetric patientswith hypertensive disease of pregnancy in argentina: Multicenter study Vasquez, D.N.
 2012
 2 3 p. 188-189
2 p.
 artikel
14 OS096. Characteristics of hypertensive disorders in twin versus singleton pregnancies Foo, J.Y.
 2012
 2 3 p. 230-231
2 p.
 artikel
15 OS082. CHIPS-Child: Testing the developmental origins hypothesis Magee, L.A.
 2012
 2 3 p. 222-223
2 p.
 artikel
16 OS002. Comparison TNF-α level and pathogen periodontal microorganismbetween normal pregnant women, periodontitis pregnant women, and lateonset severe preeclampsia women Akbar, A.
 2012
 2 3 p. 175-176
2 p.
 artikel
17 OS102. Continuing pathology following a hypertensive pregnancy and the risk of future disease Green, A.
 2012
 2 3 p. 235-
1 p.
 artikel
18 OS064. Contribute of the L-cysteine/ H2S pathway in placenta homeostasisin hypertensive disorders Sarno, L.
 2012
 2 3 p. 211-212
2 p.
 artikel
19 OS033. Correlates of maternal health outcomes associated with a low-costintervention in secondary facilities across Kano state, Nigeria Tukur, J.
 2012
 2 3 p. 194-
1 p.
 artikel
20 OS085. Decreased maternal circulating PLGF is a significant predictor of length of pregnancy in women with hypertensive disorders of pregnancy Gullai, N.
 2012
 2 3 p. 224-
1 p.
 artikel
21 OS054. Differential strain sensitivities to ischemia/reperfusion in two mouse models of fetal growth restriction Qu, X.-W.
 2012
 2 3 p. 206-
1 p.
 artikel
22 OS042. Discovery and characterization of antibody biomarkers ofpre-eclampsia and reagents for their detection Elliott, S.E.
 2012
 2 3 p. 199-200
2 p.
 artikel
23 OS039. Early prediction of preeclampsia with maternal parameters,SVEGF-R1, PLGF, Inhibin-A and PAPP-A in general population: Results from the MSPE study Tsatsaris, V.
 2012
 2 3 p. 197-198
2 p.
 artikel
24 OS012. Eclampsia with progressing disease correlates to severe diastolicblood pressure Nakamoto, O.
 2012
 2 3 p. 180-181
2 p.
 artikel
25 OS040. Effect of folic acid supplementation in pregnancy on preeclampsia– Folic acid clinical trial (FACT) Wen, S.W.
 2012
 2 3 p. 198-
1 p.
 artikel
26 OS071. Effect of methyldopa on the cerebral circulation in chronic hypertensive pregnancies Araújo, F.V.
 2012
 2 3 p. 215-216
2 p.
 artikel
27 OS020. Effects of exercise on maternal and neonatal outcomes in pregnantwomen with chronic hypertension and/or previous preecampsia: A randomized clinical trial Kasawara, K.T.
 2012
 2 3 p. 185-186
2 p.
 artikel
28 OS089. Elevated levels of the heme scavenger alpha-1-microglobulin in maternal plasma at the end of first trimester in patients who subsequently develop preeclampsia Anderson, U. Dolberg
 2012
 2 3 p. 226-227
2 p.
 artikel
29 OS075. Endothelial-dependent vascular function is significantly impaired in obesity and restored by overexpression of DDAH1: Evidence for the role of ADMA Powers, R.
 2012
 2 3 p. 218-
1 p.
 artikel
30 OS036. Ethnic differences in blood pressure and hypertensivecomplications during pregnancy; the generation R Study Bouthoorn, S.H.
 2012
 2 3 p. 195-
1 p.
 artikel
31 OS027. Ethnicity and adverse pregnancy outcomes: A cohort study Khalil, A.
 2012
 2 3 p. 190-191
2 p.
 artikel
32 OS060. Exercise training promotes placental growth and development in an animal model of preeclampsia superimposed on chronic hypertension Genest, D.S.
 2012
 2 3 p. 209-210
2 p.
 artikel
33 OS049. Exome sequencing identifies likely functional variantsinfluencing preeclampsia and CVD risk Johnson, M.
 2012
 2 3 p. 203-204
2 p.
 artikel
34 OS019. External validation of the fullPIERS model in an existing dataset of women with severe pre-eclampsia, eclampsia or HELLP syndrome Akkermans, J.
 2012
 2 3 p. 184-185
2 p.
 artikel
35 OS079. Fetal deglycosylated apolipoprotein C-III (Apo C-III0) concentration is altered in intrauterine growth restriction Pecks, U.
 2012
 2 3 p. 220-221
2 p.
 artikel
36 OS083. Fetal growth and maternal vascular function in early pregnancy Iacobaeus, C.
 2012
 2 3 p. 223-
1 p.
 artikel
37 OS078. Fetal growth restriction: A marker of severity of early-onset pre-eclampsia? Khalil, A.
 2012
 2 3 p. 220-
1 p.
 artikel
38 OS088. First trimester triple vascular test for pre-eclampsia prediction Alves, J.A. Gurgel
 2012
 2 3 p. 226-
1 p.
 artikel
39 OS006. Functional expression of endogenous ligands of Toll like receptor4 on monocytes and placentae from women during normal pregnancy andpre-eclampsia Al-Ofi, E.
 2012
 2 3 p. 178-
1 p.
 artikel
40 OS050. Genetic variants in pre-eclampsia: a meta-analysis Buurma, A.
 2012
 2 3 p. 204-
1 p.
 artikel
41 OS046. Genome-wide association scans identify novel maternalsusceptibility loci for preeclampsia Johnson, M.
 2012
 2 3 p. 202-
1 p.
 artikel
42 OS022. Global use of ultrasound for maternal mortality reduction incountries with high maternal mortality ratios Small, M.
 2012
 2 3 p. 186-187
2 p.
 artikel
43 OS097. Hemodynamic assesment by applanation tonometry in women with early and late preeclampsia Poiati, J.R.
 2012
 2 3 p. 231-
1 p.
 artikel
44 OS068. 25-Hydroxyvitamin D and angiogenic factors in early-onset severe preeclampsia Robinson, C.
 2012
 2 3 p. 214-
1 p.
 artikel
45 OS030. Hypertension and labor duration: Does it take longer? Bregand-White, J.M.
 2012
 2 3 p. 192-
1 p.
 artikel
46 OS028. Hypertensive disease in pregnancy: An examination of ethnic differences and the Hispanic paradox Small, M.
 2012
 2 3 p. 191-
1 p.
 artikel
47 OS103. Hypertensive disorders during pregnancy and cognitive decline of the offspring up to old age: the helsinki birth cohort study Tuovinen, S.
 2012
 2 3 p. 235-236
2 p.
 artikel
48 OS043. Identification and validation of novel markers for the predictionof pre-eclampsia Myers, J.
 2012
 2 3 p. 200-
1 p.
 artikel
49 OS095. Impedance cardiography: A straightforward and reliable tool to evaluate differences of cardiac reflex response between normal pregnancy and pre-eclampsia Tomsin, K.
 2012
 2 3 p. 230-
1 p.
 artikel
50 OS098. Increased adiposity decreases the intensity myeloperoxidase in neutrophils from pregnant women at delivery Gandley, R.E.
 2012
 2 3 p. 231-232
2 p.
 artikel
51 OS105. Increased left ventricular mass index in normotensive formerly preeclamptic women is associated with the later development of chronic hypertension Ghossein, C.
 2012
 2 3 p. 236-237
2 p.
 artikel
52 OS066. Intrauterine CYP2J2 expression and circulatingepoxyeicosatrienoic acid levels in preeclampsia Herse, F.
 2012
 2 3 p. 212-213
2 p.
 artikel
53 OS031. Lifestyle intervention after complicated pregnancy successfully improves cardiovascular and metabolic health: Results of the pro-active study Berks, D.
 2012
 2 3 p. 192-193
2 p.
 artikel
54 OS109. Lifestyle intervention after complicated pregnancy successfully improves saturated fat-intake, but not exercise and smoking habits: results of the pro-active study Berks, D.
 2012
 2 3 p. 239-
1 p.
 artikel
55 OS069. Light, a TNF superfamily member, contributes to pathophysiology in a mouse model of preeclampsia Wang, W.
 2012
 2 3 p. 214-
1 p.
 artikel
56 OS034. Magnesium sulfate for prevention of eclampsia: Are intramuscularand intravenous regimens equivalent? Easterling, T.
 2012
 2 3 p. 194-
1 p.
 artikel
57 OS011. Management of late preterm pregnancy complicated by mildpreeclampsia: A prospective randomized trial Martin Jr., J.N.
 2012
 2 3 p. 180-
1 p.
 artikel
58 OS080. Maternal and fetal lipoprotein concentrations and expression of placental lipoprotein transporters in pre-eclampsia and normotensive controls Hentschke, M.R.
 2012
 2 3 p. 221-
1 p.
 artikel
59 OS087. Maternal characteristics, mean arterial pressure and PLGF in early prediction of preeclampsia Kuc, S.
 2012
 2 3 p. 225-226
2 p.
 artikel
60 OS017. Maternal death risk factor score based on hospital reference pattern and maternal condition of eclamptic woman in Soetomo Hospital, Surabaya, Indonesia Akbar, A.
 2012
 2 3 p. 183-
1 p.
 artikel
61 OS084. Maternal haemodynamics at 11–13 weeks of gestation and adverse pregnancy outcomes Khalil, A.
 2012
 2 3 p. 223-224
2 p.
 artikel
62 OS018. Maternal mortality and its mainly possible causepre-eclampsia/eclampsia in developing country (Surabaya-Indonesia as themodel) Akbar, A.
 2012
 2 3 p. 184-
1 p.
 artikel
63 OS086. Methylation status of the HOXA13 promoter region in placental tissue of pregnancies complicated by early onset severe preeclampsia Rambaldi, M.P.
 2012
 2 3 p. 224-225
2 p.
 artikel
64 OS037. Minipiers (pre-eclampsia integrated estimate of risk):Development of a clinical prediction model for use in low and middleincome countries (LMIC) Payne, B.
 2012
 2 3 p. 195-196
2 p.
 artikel
65 OS048 Mitochondrial content and function in placental cells and tissuesof preeclampsia and IUGR Mando’, C.
 2012
 2 3 p. 203-
1 p.
 artikel
66 OS044. Morphological differences in murine placenta detected by magneticresonance imaging measurements of T2 relaxation times in mouse models ofpreeclampsia Bobek, G.
 2012
 2 3 p. 200-201
2 p.
 artikel
67 OS045. Multi-dimensional protein identification technology analysis of syncytiotrophoblast vesicles released from perfused preeclampsia placentas Tannetta, D.
 2012
 2 3 p. 201-202
2 p.
 artikel
68 OS081. Novel KCNQ3/KCNE5 isoform protein and mRNA expression in first trimester human placentae Mistry, H.D.
 2012
 2 3 p. 221-222
2 p.
 artikel
69 OS073. Over-expression of MIRNA-203 results in increased inflammatory response in endothelial cells: a mechanism of increased endothelial inflammatory response in preeclampsia Dong, Q.
 2012
 2 3 p. 217-
1 p.
 artikel
70 OS062. Oxidative stress mediates podocyte injury in preeclampsia Zhao, S.
 2012
 2 3 p. 210-211
2 p.
 artikel
71 OS057. Pathophysiological role of elevated tissue transglutaminase in autoantibody-induced features of preeclampsia in pregnant mice Liu, C.
 2012
 2 3 p. 208-
1 p.
 artikel
72 OS090. Performance of candidate clinical and biochemical markers in screening early in pregnancy to detect women at high risk to develop preeclampsia Forest, J.-C.
 2012
 2 3 p. 227-
1 p.
 artikel
73 OS032. Pharmacotherapy for pre-eclampsia in low and middle income countries: An analysis of essential medicines lists (EMLS) Lalani, S.
 2012
 2 3 p. 193-194
2 p.
 artikel
74 OS065. Placental growth factor as a diagnostic and prognostic test forplacental complications of pregnancy Ris-Stalpers, C.
 2012
 2 3 p. 212-
1 p.
 artikel
75 OS061. Placental growth factor reduces blood pressure and proteinuria in experimental preeclampsia Makris, A.
 2012
 2 3 p. 210-
1 p.
 artikel
76 OS025. Placental malaria infection as a risk factor for hypertensivedisorders of pregnancy in malaria endemic regions: A systematic review and meta-analysis Bodkin, B.L.
 2012
 2 3 p. 189-
1 p.
 artikel
77 OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study Chappell, L.C.
 2012
 2 3 p. 233-234
2 p.
 artikel
78 OS023. Postpartum cardiovascular disease risk factors in women with ahistory of early onset preeclampsia, late onset preeclampsia and pregnancy induced hypertension Breimer, A.Y.
 2012
 2 3 p. 188-
1 p.
 artikel
79 OS038. Pre-conceptional preparation of women with chronic hypertensionof I–II stage II of the degree of risk of CHF 0–I and recurrent bacterial vaginosis Kuznetsova, E.
 2012
 2 3 p. 196-197
2 p.
 artikel
80 OS052. Preeclampsia candidate genes differentially methylated in maternal leukocyte DNA White, W.
 2012
 2 3 p. 205-
1 p.
 artikel
81 OS108. Preeclamptic women display salt sensitivity and cardiovascular damage before their menopause Martillotti, G.
 2012
 2 3 p. 238-
1 p.
 artikel
82 OS107. Pregnancies involving hypertensive disorders of pregnancy are associated with posttraumatic stress disorder Porcel, J.
 2012
 2 3 p. 237-238
2 p.
 artikel
83 OS001. Pregnancy outcome in subsequent pregnancies after eclampsia Gainder, S.
 2012
 2 3 p. 175-
1 p.
 artikel
84 OS093. Prevalance of sleep disordered breathing in pregnancy Robertson, A.
 2012
 2 3 p. 228-229
2 p.
 artikel
85 OS092. qPCR-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia Penning, M.
 2012
 2 3 p. 228-
1 p.
 artikel
86 OS047. Quantification of placental vascularization in a rabbit model ofIUGR with three-dimensional power doppler angiography Lecarpentier, E.
 2012
 2 3 p. 202-203
2 p.
 artikel
87 OS013. Reduction of preeclampsia related complications with with theNO-donor penterythriltetranitrat (petn) in risk pregnancies – Aprospective randomized double-blind placebo pilot study Groten, T.
 2012
 2 3 p. 181-
1 p.
 artikel
88 OS072. Regional distribution of cerebral white matter lesions years following (pre)eclampsia Wiegman, M.J.
 2012
 2 3 p. 216-217
2 p.
 artikel
89 OS016. Retinal vascular changes in hypertensive disorders of pregnancy Lupton, S.J.
 2012
 2 3 p. 182-183
2 p.
 artikel
90 OS021. Risk factors and outcomes of maternal obesity and excessive weight gain during pregnancy Gaillard, R.
 2012
 2 3 p. 186-
1 p.
 artikel
91 OS009. Second trimester serum hyperglycosylated human chorionic gonadotrophin and preeclampsia Keikkala, E.
 2012
 2 3 p. 179-
1 p.
 artikel
92 OS029. Severe anemia, sickle cell disease, and thalassemia as riskfactors for preeclampsia in developing countries Zhang, J.J.
 2012
 2 3 p. 191-192
2 p.
 artikel
93 OS055. Sex-dependent differences in expression of FLT-1 variants andJMJD6 in mouse placenta Surmon, L.
 2012
 2 3 p. 206-207
2 p.
 artikel
94 OS070. Shared genetic risk factors for preeclampsia and cardiovascular disease Løset, M.
 2012
 2 3 p. 214-215
2 p.
 artikel
95 OS026. Study of neuroradiological and biochemical abnormalities in 100 women with preeclampsia-eclapmsia Tatapudi, R.
 2012
 2 3 p. 190-
1 p.
 artikel
96 OS094. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: A 2D speckle tracking imaging study Shahul, S.
 2012
 2 3 p. 229-230
2 p.
 artikel
97 OS007. The apoptosis markers are altered in CD4+CD25+FOXP3+ T regulatorylymphocytes in pre-eclampsia Darmochwal-Kolarz, D.A.
 2012
 2 3 p. 178-
1 p.
 artikel
98 OS101. The brain study: cognition, quality of life and social functioning following preeclampsia Postma, I.R.
 2012
 2 3 p. 234-235
2 p.
 artikel
99 OS099. The chips trial (control of hypertension in pregnancy study) Magee, L.A.
 2012
 2 3 p. 232-
1 p.
 artikel
100 OS077. The chromosome 2q22 preeclampsia susceptibility locus reveals shared novel risk factors for CVD Moses, E.
 2012
 2 3 p. 219-220
2 p.
 artikel
101 OS076. The effect of lectin-like oxidized low density lipoprotein receptor monoclonal antibody (LOX-1 MAb) on the expression of eNOS in preeclamptic HUVECs model Keman, K.
 2012
 2 3 p. 218-219
2 p.
 artikel
102 OS003. The influence of gestational weight gain on the development ofgestational hypertension in obese women Joy, S.
 2012
 2 3 p. 176-
1 p.
 artikel
103 OS091. The origin of preeclampsia in diet-induced maternal endothelial stiffness Hart, N.R.
 2012
 2 3 p. 227-228
2 p.
 artikel
104 OS106. The postpartum preeclampsia clinic (PPPEC) – an interdisciplinary clinic for cardiovascular risk reduction for women with preeclampsia Sia, W.W.
 2012
 2 3 p. 237-
1 p.
 artikel
105 OS005. Treatment with magnesium sulphate reduced the serum level of IL-6in preeclamptic women Xiao, J.
 2012
 2 3 p. 177-
1 p.
 artikel
106 OS053. Trophoblast invasion in the mesometrial triangle of atp infused pregnant rats Spaans, F.
 2012
 2 3 p. 205-206
2 p.
 artikel
107 OS010. Use of retinal imaging to characterise physiological vascularchanges throughout pregnancy Lupton, S.J.
 2012
 2 3 p. 179-180
2 p.
 artikel
108 OS067. VEGF, a novel stimulator of aldosterone production Gennari-Moser, C.
 2012
 2 3 p. 213-
1 p.
 artikel
109 OS063. Vitamin D promotes endothelial progenitor cell differentiationand upregulates VEGF Grundmann, M.
 2012
 2 3 p. 211-
1 p.
 artikel
110 OS051. Web-based scientific data management and standardized specimencollection-important tools for research and scientific exchange Wild, J.
 2012
 2 3 p. 204-205
2 p.
 artikel
111 OS015. What is the optimal time for delivery in women with gestationalhypertension? Cruz, M.O.
 2012
 2 3 p. 182-
1 p.
 artikel
112 OS014. Which first-line drug to control severe hypertension in pregnancy? A pilot study Saudan, P.
 2012
 2 3 p. 182-
1 p.
 artikel
113 PP094. A comparison of gestational changes in urinary excretion of magnesium with those of calcium Yamasaki, M.
 2012
 2 3 p. 291-
1 p.
 artikel
114 PP046. Adherence to exercise with bicycle during pregnancy in women with risk of preeclampsia Kasawara, K.T.
 2012
 2 3 p. 266-267
2 p.
 artikel
115 PP009. A follow-up study of Finnish pre-eclampsia families identifies a new fetal susceptibility locus on chromosome 18 Laivuori, H.M.
 2012
 2 3 p. 244-245
2 p.
 artikel
116 PP089. A new expectant management of early-onset preeclampsia Shen, Y.
 2012
 2 3 p. 289-
1 p.
 artikel
117 PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies Rana, S.
 2012
 2 3 p. 273-274
2 p.
 artikel
118 PP085. Angiotensin II type 1 receptor antibodies increase angiotensin II sensitivity in pregnant rats Wenzel, K.
 2012
 2 3 p. 286-287
2 p.
 artikel
119 PP003. Antagonism in A2A and A2B adenosine receptor on fetal endothelium proliferation involves a nitric oxide-depended intracellular pathway in early and late-onset pre-eclampsia Acurio, J.
 2012
 2 3 p. 241-242
2 p.
 artikel
120 PP178. Antenatal sFlt1 and PlGF levels at 20–28weeks of gestation for prediction of the occurrence of preeclampsia: A preliminary report Jantarasaengaram, S.
 2012
 2 3 p. 337-
1 p.
 artikel
121 PP042. Anti-hypertensive drugs hydralazine, clonidine and labetalol improve trophoblast integration into endothelial cellular networks in vitro Xu, B.
 2012
 2 3 p. 264-
1 p.
 artikel
122 PP167. A process evaluation of an innovative implementation strategy of the Dutch guidelines on hypertensive disorders in pregnancy using a computerized decision support system Luitjes, S.
 2012
 2 3 p. 329-330
2 p.
 artikel
123 PP126. Are placental fas and fas ligand gene polymorphisms associated with preeclampsia? Hsu, C.-D.
 2012
 2 3 p. 307-
1 p.
 artikel
124 PP163. Are we using magnesium sulphate excessively for preeclamptic patients? Calandrino, R.
 2012
 2 3 p. 327-328
2 p.
 artikel
125 PP038. Are women with gestational hypertension or preeclampsia at an increased long term risk of kidney function impairment? Bhattacharya, S.
 2012
 2 3 p. 262-
1 p.
 artikel
126 PP103. Arterial stiffness in women with previous GDM – A follow up of Chinese HAPO study cohort Tam, W.H.
 2012
 2 3 p. 295-
1 p.
 artikel
127 PP129. Assessment of oxidative status markers and no bioavailability in hypertensive disorders of pregnancy Sandrim, V.
 2012
 2 3 p. 308-
1 p.
 artikel
128 PP020 Association between renal dysfunction and angiogenic factors in preeclampsia Costa, R.A.D.A.
 2012
 2 3 p. 252-
1 p.
 artikel
129 PP161. Association of maternal vitamin D and placenta growth factor with early-onset severe preeclampsia Robinson, C.
 2012
 2 3 p. 326-
1 p.
 artikel
130 PP080. Blood pressure in the offspring of experimental preeclamptic and normotensive baboon pregnancies Yeung, K.
 2012
 2 3 p. 283-284
2 p.
 artikel
131 PP136. Blood pressure patterns in pregnant women who developed pre-eclampsia or hypertension Steyn, W.
 2012
 2 3 p. 312-314
3 p.
 artikel
132 PP097. Cardiac output and systemic vascular resistance in normal pregnancy and in control non-pregnant women Khalil, A.
 2012
 2 3 p. 292-293
2 p.
 artikel
133 PP018 Cardiac reflex responses measured by impedance cardiography are different between low and high cardiac output pre-eclampsia Tomsin, K.
 2012
 2 3 p. 251-
1 p.
 artikel
134 PP030. Cardiovascular disease and risk in a pregnant woman’s father as a risk factor for preeclampsia Parker, C.E.
 2012
 2 3 p. 258-
1 p.
 artikel
135 PP036. Cardiovascular disease risk factors among women with a history of placental abruption Veerbeek, J.H.W.
 2012
 2 3 p. 261-
1 p.
 artikel
136 PP034. Cardiovascular outcomes remote from pregnancy in women with HDP: 23–32years following delivery Tooher, J.
 2012
 2 3 p. 260-
1 p.
 artikel
137 PP107. Cardiovascular parameters 40 years after hypertensive pregnancies Hellgren, M.
 2012
 2 3 p. 297-
1 p.
 artikel
138 PP068. Catastrophic antiphospholipid-syndrome (CAPS) – A severe pregnancy complication Schlembach, D.
 2012
 2 3 p. 278-
1 p.
 artikel
139 PP074. Characteristic changes in endothelial function in uterine artery by administration of no synthase inhibitor during period of placental formation Suzuki, Y.
 2012
 2 3 p. 281-
1 p.
 artikel
140 PP099. Chronic hypertension: follow-up of chronic hypertension pregnant women in 2008–2009 Caeiro, A.F.
 2012
 2 3 p. 293-294
2 p.
 artikel
141 PP016. Circulating lymphangiogenic factors in preeclampsia Lely, T.
 2012
 2 3 p. 249-250
2 p.
 artikel
142 PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction Sibiude, J.
 2012
 2 3 p. 302-303
2 p.
 artikel
143 PP083. Clinic and out-of-clinic blood pressure changes during pregnancy by parity: Boshi study Ishikuro, M.
 2012
 2 3 p. 285-
1 p.
 artikel
144 PP127. CMV infection and TLR2 expression in HELLP syndrome Xie, F.
 2012
 2 3 p. 307-308
2 p.
 artikel
145 PP132 Comparison between Early-onset and Late-onset Preeclampsia based on maternal cardiac output, Total Peripheral Vascular Resistance, and Uterine Artery Resistance Index Akbar, A.
 2012
 2 3 p. 310-
1 p.
 artikel
146 PP017 Comparison of vascular function in preeclamptic and normotensive pregnant women in the rural eastern Cape province of South Africa Namugowa, A.V.
 2012
 2 3 p. 250-251
2 p.
 artikel
147 PP049. Could the supplementation of L-arginine plus folic acid T improve reduced endothelial function seen in preeclampsia? Suzuki, Y.
 2012
 2 3 p. 268-
1 p.
 artikel
148 PP087. Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women Graves, S.W.
 2012
 2 3 p. 287-288
2 p.
 artikel
149 PP053. Development and validation of a model for prepregnant prediction of recurrence of early-onset preeclampsia Van Kuijk, S.M.
 2012
 2 3 p. 270-271
2 p.
 artikel
150 PP015. Differential expression of Nrf2 and VEGF in human placental beds from normal and pregnancies complicated with preeclampsia and IUGR Kweider, N.
 2012
 2 3 p. 248-249
2 p.
 artikel
151 PP050. Distribution of ABO and Rhesus blood groups in patients withpre-eclampsia Hentschke, M.R.
 2012
 2 3 p. 268-269
2 p.
 artikel
152 PP065. dNK and dNK-CM mediated alterations of DNA methylation in extravillous cytotrophoblasts (EVTS) Hu, Y.
 2012
 2 3 p. 277-
1 p.
 artikel
153 PP010. Does aldosterone participate in placental angiogenesis via PLGF? Eisele, N.
 2012
 2 3 p. 245-
1 p.
 artikel
154 PP043. Do women know what pre-eclampsia is? What is the level of knowledge of the disease in a small population connected to a social net? Mosca, C.P.
 2012
 2 3 p. 264-265
2 p.
 artikel
155 PP152. Eclampsia concurrent with HELLP syndrome – A sixteen-year clinical experience in an academic medical center Liu, C.-M.
 2012
 2 3 p. 321-
1 p.
 artikel
156 PP077. Effect of maternal antioxidant concentrations on expressions of angiogenesis-related genes in the villous trophoblasts from early pregnancy Koide, K.
 2012
 2 3 p. 282-
1 p.
 artikel
157 PP007. Effects of STAT1 suppression on ERK1/2 in trophoblastic cells Sousa, F.L.P.
 2012
 2 3 p. 243-
1 p.
 artikel
158 PP075. Endothelial dysfunction may be impaired by increased oxidative stress in preeclamptic women Watanabe, K.
 2012
 2 3 p. 281-
1 p.
 artikel
159 PP160. Endothelial dysfunction with obesity, pregnancy and preeclampsia Raymond, D.
 2012
 2 3 p. 325-326
2 p.
 artikel
160 PP130. ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy Sandrim, V.
 2012
 2 3 p. 308-309
2 p.
 artikel
161 PP014. Estimating fully and minimal oxidized low density lipoprotein accumulation in placental tissue in intrauterine growth restriction and healthy controls Pecks, U.
 2012
 2 3 p. 248-
1 p.
 artikel
162 PP123. Evaluation of glycosaminoglycans in placental of pregnant women with and without preeclampsia Sass, N.
 2012
 2 3 p. 305-306
2 p.
 artikel
163 PP071. Evaluation of maternal–fetal doppler parameters and of whole blood nitrite throughout gestation Cavalli, R.C.
 2012
 2 3 p. 279-280
2 p.
 artikel
164 PP079. Evidence of placental and vascular endothelial apotosis and dysfunction by elevated serum human chorionic gonadotropin, soluble selectin and soluble Fas in HELLP syndrome Hsu, C.-D.
 2012
 2 3 p. 283-
1 p.
 artikel
165 PP121. Expression of PlGF, sFlt, MTF-1, HO-1 and HIF-1 alpha mRNAs in preeclampsia placenta and effect of preeclampsia sera on their expression of choriocarcinoma cells Maebayashi, A.
 2012
 2 3 p. 304-305
2 p.
 artikel
166 PP040. Expression of RANTES (CCL5) in maternal plasma, fetal plasma and placenta in pre-eclampsia and normotensive controls Hentschke, M.R.
 2012
 2 3 p. 263-
1 p.
 artikel
167 PP037. Family history of cardiovascular disease and maternal vascular function during early pregnancy Iacobaeus, C.
 2012
 2 3 p. 261-262
2 p.
 artikel
168 PP072. Features of intrarenal blood flow in patients with preeclampsia (PE) Kirsanova, T.
 2012
 2 3 p. 280-
1 p.
 artikel
169 PP114. First trimester multi-parameter prediction of pre-eclampsia Gurgel Alves, J.A.
 2012
 2 3 p. 301-302
2 p.
 artikel
170 PP029. Gestational hypertension and birth weight in twin pregnancies Ferrazzani, S.
 2012
 2 3 p. 257-258
2 p.
 artikel
171 PP073. Gestational hypertension: A study on placental expression of endothelial and inducible nitric oxide synthase and no metabolism Mazzanti, L.
 2012
 2 3 p. 280-281
2 p.
 artikel
172 PP175. Gestational hypertensive syndromes: Risk factors identification and complications in a primiparous population Amaral, W.T.
 2012
 2 3 p. 335-
1 p.
 artikel
173 PP095. Guideline-based development of quality indicators for hypertensive diseases in pregnancy Luitjes, S.
 2012
 2 3 p. 291-292
2 p.
 artikel
174 PP166. HELLP syndrome: Challenges for establishing diagnostic criteria Moraes, K.R.
 2012
 2 3 p. 329-
1 p.
 artikel
175 PP033. High blood pressure in pregnancy: an indicator of future health outcomes Tooher, J.
 2012
 2 3 p. 260-
1 p.
 artikel
176 PP125. High mobility group box 1 protein (HMGB1): A pathogenic role in preeclampsia? Pradervand, P.-A.
 2012
 2 3 p. 306-307
2 p.
 artikel
177 PP156. High prevalence of pre-pregnancy overweight and obesity associated with maternal and perinatal complications Cidade, D.G.
 2012
 2 3 p. 323-
1 p.
 artikel
178 PP171. Hospitalized preterm mild preeclamptics: Is there a difference in outcomes between isolated or superimposed disease? Lewis, D.F.
 2012
 2 3 p. 332-333
2 p.
 artikel
179 PP138. Human fetal malformations associated with the use of angiotensin II receptor antagonist Korkes, H.
 2012
 2 3 p. 314-315
2 p.
 artikel
180 PP120. Hydatidiform mole as a cause of eclampsia in the first trimester: A case report Ottanelli, S.
 2012
 2 3 p. 304-
1 p.
 artikel
181 PP102. Hypertension in pregnancy and long term cardiovascular mortality outcomes Tooher, J.
 2012
 2 3 p. 295-
1 p.
 artikel
182 PP151. Hypertensive complications in pregnancy – Two year study (2008–2009) Dias, G.
 2012
 2 3 p. 321-
1 p.
 artikel
183 PP158. Hypertensive disorders in pregnant women affected by type I diabetes Ferrazzani, S.
 2012
 2 3 p. 324-325
2 p.
 artikel
184 PP145. Hypertensive disorders of pregnancy: A two year study (2008–2009) Landim, E.
 2012
 2 3 p. 318-
1 p.
 artikel
185 PP149. Hypertensive risk factors: Do they influence pregnancy outcome in women affected by new onset pre-eclampsia? Gerosa, V.
 2012
 2 3 p. 319-320
2 p.
 artikel
186 PP026. Hyperuricemia in the prognosis of adverse perinatal outcomes Escudero, C.
 2012
 2 3 p. 256-257
2 p.
 artikel
187 PP011. Increased placental expression of angiogenin inhibitor (Ribonuclease inhibitor), a novel gene in pre-eclampsia Karanam, V.L.
 2012
 2 3 p. 245-246
2 p.
 artikel
188 PP142. Independent effects of pregnancy induced hypertension on childhood development: A retrospective cohort study Campbell, D.
 2012
 2 3 p. 316-
1 p.
 artikel
189 PP172. Indian scenario of preeclampsia and its consequences and early prophylaxis Jariwala, M.C.
 2012
 2 3 p. 333-
1 p.
 artikel
190 PP159. In women with previous pregnancy hypertension, cardiovascular risk biomarkers may be modulated by haptoglobin genotype Bicho, M.D.P.
 2012
 2 3 p. 325-
1 p.
 artikel
191 PP118. Is the placental mass associated with the severity of preeclampsia? Baumann, M.
 2012
 2 3 p. 303-
1 p.
 artikel
192 PP148. Is there podocyturia in pregnant women with chronic hypertension? (Preliminary results) Roberto, F.B.
 2012
 2 3 p. 319-
1 p.
 artikel
193 PP122. Lack of correlation between placental weight and circulating soluble fms-like tyrosine kinase-1 and placental growth factor suggests trophoblastic activity as a major contributor to the serum pool Wataganara, T.
 2012
 2 3 p. 305-
1 p.
 artikel
194 PP134. l-Arginine supplementation induces the expression of genes related to antioxidant defense in cultures of human vascular endothelial cells: Protective role for preeclampsia Espejel-Nuñez, A.
 2012
 2 3 p. 311-312
2 p.
 artikel
195 PP098. Lipidic fingerprinting in women with early-onset preeclampsia: A first look Oliveira, L. De
 2012
 2 3 p. 293-
1 p.
 artikel
196 PP008. Lipotoxicity and preeclampsia: A probable correlation (preliminary results) Scarpelini, M.
 2012
 2 3 p. 244-
1 p.
 artikel
197 PP164. Magnesium sulphate for prevention and treatment of eclampsia in low and middle income countries: Systematic review of tested regimens Gordon, R.M.
 2012
 2 3 p. 328-
1 p.
 artikel
198 PP084. Magnetic resonance imaging measurements of T2 relaxation times within contrasting regions of murine placenta is dependent upon blood flow Bobek, G.
 2012
 2 3 p. 286-
1 p.
 artikel
199 PP169. Management of fetal and maternal prognosis during severe toxemia Radhouane, M.
 2012
 2 3 p. 330-331
2 p.
 artikel
200 PP093 Maternal and fetal outcomes in oocyte donor pregnancies Corradetti, A.
 2012
 2 3 p. 290-291
2 p.
 artikel
201 PP070. Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period Cavalli, R.C.
 2012
 2 3 p. 279-
1 p.
 artikel
202 PP045. Maternal mortality due to hypertension: A look at the puerperium Bordinoski, L.F.
 2012
 2 3 p. 266-
1 p.
 artikel
203 PP180. Maternal plasma endotoxin increases significantly across pregnancy with no association with obesity, inflammation, or insulin sensitivity Powers, R.
 2012
 2 3 p. 337-338
2 p.
 artikel
204 PP135. Maternal serum levels of endothelial nitric oxide synthase and ADMA, an endogenous ENOS inhibitor in pregnancies complicated by severe preeclampsia Laskowska, M.
 2012
 2 3 p. 312-
1 p.
 artikel
205 PP060. Matrix metalloproteinases-2 and -9 and their inhibitors: A role in the development of pre-eclampsia? Mckirdy, A.
 2012
 2 3 p. 274-275
2 p.
 artikel
206 PP117. Measurement of sFlt-1 and PlGF for prediction of pregnancy associated diseases Stubert, J.
 2012
 2 3 p. 303-
1 p.
 artikel
207 PP105. Mental health problems following preeclampsia or HELLP syndrome: Do we have a case? A systematic review Delahaije, D.
 2012
 2 3 p. 296-
1 p.
 artikel
208 PP064. M1 Monocyte subpopulation is associated with pro-inflammatory cytokineproduction in pregnant women with preeclampsia Medeiros, L.T.L.
 2012
 2 3 p. 276-277
2 p.
 artikel
209 PP012. Morphometric analysis of the differences in placental angiogenesis during early and late-onset pre-eclampsia Escudero, C.
 2012
 2 3 p. 246-
1 p.
 artikel
210 PP005. Natriuretic peptide precursor B gene (TTTC)N microsatellite polymorphism and elevated BNP levels in early onset pre-eclampsia Szabó, G.
 2012
 2 3 p. 242-243
2 p.
 artikel
211 PP153. Noninvasive assessment of maternal hemodynamic function by electrical impedance cardiography (EIC) and correlation with uterine and umbilical vascular resistance in mid-pregnancy Woelkers, D.A.
 2012
 2 3 p. 321-322
2 p.
 artikel
212 PP113. NT-Pro-BNP: A predictor of adverse maternal outcomes in hypertensive gestational syndromes? Cabo Fustaret, M.C.
 2012
 2 3 p. 301-
1 p.
 artikel
213 PP082. Ophthalmic artery doppler for identification of severe preeclampsia in pregnancies complicated by hypertension Oliveira, C.A.D.
 2012
 2 3 p. 284-285
2 p.
 artikel
214 PP088. Oral antihypertensive therapy for severe hypertension in pregnancy Firoz, T.
 2012
 2 3 p. 288-
1 p.
 artikel
215 PP076. Oscillation of blood pressure seen in eclamptic women Suzuki, Y.
 2012
 2 3 p. 281-282
2 p.
 artikel
216 PP021 Outcomes for adolescent women and their pregnancies in greater Western Sydney Garner, A.J.
 2012
 2 3 p. 252-
1 p.
 artikel
217 PP047. Outpatient management of pregnancy complicated by mild hypertensive disorders Giannubilo, S.R.
 2012
 2 3 p. 267-
1 p.
 artikel
218 PP013. Oxidized low density lipoprotein accumulation and the expression of the lectin-like oxLDL receptor (LOX-1) in placental tissue in preeclampsia and healthy controls Pecks, U.
 2012
 2 3 p. 247-248
2 p.
 artikel
219 PP128. Placental Caspase-3 gene polymorphisms is associated with preeclampsia Hsu, C.-D.
 2012
 2 3 p. 308-
1 p.
 artikel
220 PP056. Placental growth factor is a better predictor of preterm birth than uterine or umbilical artery doppler in hypertensive disorders of pregnancy Stenczer, B.
 2012
 2 3 p. 272-
1 p.
 artikel
221 PP035. Placental klotho protein in preeclampsia: A possible link to long term outcomes Giannubilo, S.R.
 2012
 2 3 p. 260-261
2 p.
 artikel
222 PP137. Posterior reversible encephalopathy syndrome (PRES) is a constant component of eclampsia Martin Jr., J.N.
 2012
 2 3 p. 314-
1 p.
 artikel
223 PP108. Post-partum evaluation of the blood pressure and the kidney function in pre-eclamptic women Pechère-Bertschi, A.
 2012
 2 3 p. 297-298
2 p.
 artikel
224 PP054. Predicting preeclampsia at late mid-term pregnancy before occurrence of clinical symptoms: Clinical utility of biomarkers and clinical parameters in a low-risk population Forest, J.-C.
 2012
 2 3 p. 271-
1 p.
 artikel
225 PP112. Prediction of preeclampsia based on clinical risk factors: A prospective high-risk cohort study Wong, T.Y.
 2012
 2 3 p. 300-301
2 p.
 artikel
226 PP051. Prediction of preeclampsia with the sFlt-1/PLGF ratio: impact of the slope of repeated measurements Schoofs, K.
 2012
 2 3 p. 269-
1 p.
 artikel
227 PP101. Preeclampsia and pregnancy induced hypertension and carotid artery atherosclerosis Sharashkina, N.
 2012
 2 3 p. 294-295
2 p.
 artikel
228 PP100. Pre-eclampsia: Risk factors and outcomes – A two-year study Santos, A.V.
 2012
 2 3 p. 294-
1 p.
 artikel
229 PP104. Pregnancy-induced hypertension is a strong risk factor for hypertension just 5 years after delivery: A double cohort study at the National Center for Child Health and Development and Showa University Hospital, Tokyo Mito, A.
 2012
 2 3 p. 295-296
2 p.
 artikel
230 PP150. Pregnancy outcome in women with heart disease in a single tertiary care center Hink, E.
 2012
 2 3 p. 320-
1 p.
 artikel
231 PP055. Preliminary results of the more prepared study (microparticle orientated risk evaluation in the prediction of preeclampsia among risk gravidas): A multicenter prospective prognostic marker study Fitzgerald, J.S.
 2012
 2 3 p. 271-272
2 p.
 artikel
232 PP091. Prematurity and hypertensive disorders in pregnancy. A major public health problem Silveira, M.R.F.
 2012
 2 3 p. 289-290
2 p.
 artikel
233 PP170. Prenatal vitamin C and E supplementation is associated with a reduction in placental abruption and preterm birth in smokers Gandley, R.
 2012
 2 3 p. 331-332
2 p.
 artikel
234 PP147. Prevalence of hypertensive syndromes according to pregnancy age Dias, G.M.
 2012
 2 3 p. 318-319
2 p.
 artikel
235 PP144. Profile of lupus pregnancy in internal medecine practice Haddad, T.
 2012
 2 3 p. 317-318
2 p.
 artikel
236 PP044. Profile of pregnant women with pre-eclampsia treated in priority area Marçal, V.M.G.
 2012
 2 3 p. 265-
1 p.
 artikel
237 PP146. Psychological assessment of renal transplant recipients during pregnancy Neto, V.L.L. Belardi
 2012
 2 3 p. 318-
1 p.
 artikel
238 PP048. Questionnaire for obstetricians and neurosurgeons on brain stroke and hypertension in pregnancy in/around Nara Prefecture, Japan Naruse, K.
 2012
 2 3 p. 267-268
2 p.
 artikel
239 PP024. Random urine albumin: Creatinine ratio in high-risk pregnancy – Is it clinically useful? De Silva, D.A.
 2012
 2 3 p. 253-255
3 p.
 artikel
240 PP131. Regulation of heme oxygenase/carbon monoxide (ho/co) and l-arginine/nitric oxide (no) pathways by human chorionic gonadotropin (hcg) in human fetal endothelium Palma, C.
 2012
 2 3 p. 309-310
2 p.
 artikel
241 PP115. Relationship between angiogenic factors and preeclampsia: Preliminary results Daher, S.
 2012
 2 3 p. 302-
1 p.
 artikel
242 PP143. Relationship between mid-pregnancy placenta growth factor and hemodynamics in the mother, fetus, and uterus Woelkers, D.A.
 2012
 2 3 p. 317-
1 p.
 artikel
243 PP155. Relationship between overnight blood pressure and snoring during pregnancy Robertson, A.
 2012
 2 3 p. 322-323
2 p.
 artikel
244 PP154. Relationship between recorded and reported snoring during pregnancy: Objective measurement versus questionnaire responses Robertson, A.
 2012
 2 3 p. 322-
1 p.
 artikel
245 PP066. Renal artery stenosis revealed by an early-onset preeclampsia: A series of 6 cases Pourrat, O.
 2012
 2 3 p. 277-278
2 p.
 artikel
246 PP106. Risk of long term renal graft loss after pregnancy in renal transplant recipients immunosuppressed with calcineurin inhibitors Cararach, V.
 2012
 2 3 p. 297-
1 p.
 artikel
247 PP109. Risk of preeclampsia in homologous and oocyte donation IVF pregnancies Simeone, S.
 2012
 2 3 p. 298-
1 p.
 artikel
248 PP157. Risk of preeclampsia in pregnant women with gestational diabetes in Alberta Nerenberg, K.A.
 2012
 2 3 p. 323-324
2 p.
 artikel
249 PP092. Satisfaction and experiences of pregnant hypertensive women participating in a feasibility study of guided imagery effects on blood pressure Moffatt, F. Wight
 2012
 2 3 p. 290-
1 p.
 artikel
250 PP133. Second and third trimester placental haemodynamics and the risks of pregnancy complications. The generation R study Gaillard, R.
 2012
 2 3 p. 310-311
2 p.
 artikel
251 PP176. SFLT-1: A possibility of precocious diagnosis of preeclampsia Olmos, C.S.
 2012
 2 3 p. 335-336
2 p.
 artikel
252 PP162. sFlt-1 controlled by CPAP in a pregnant patient with chronic hypertension Daly, A.L.
 2012
 2 3 p. 327-
1 p.
 artikel
253 PP062. Silibinin modulates NF-kB pathway and proinflammatory cytokines production by mononuclear cells of preeclamptic women Giorgi, V.S.I.
 2012
 2 3 p. 275-276
2 p.
 artikel
254 PP081. Study group obstetrics – A platform for efficient collaboration and networking in obstetrical science Kuessel, L.
 2012
 2 3 p. 284-
1 p.
 artikel
255 PP002. Study of polymorphisms of the adiponectin gene in women with gestational hypertension and preeclampsia Machado, J.S.R.
 2012
 2 3 p. 241-
1 p.
 artikel
256 PP004. Study of the methylenetetrahydrofolate reductase and the reduced-folate carrier-1 gene polymorphism in healthy and severe pre-eclamptic patients Szabó, G.
 2012
 2 3 p. 242-
1 p.
 artikel
257 PP058. The additive effect of plasma levels of sFlt-1/PLGF ratio following the risk classification using both blood pressure levels and uterine artery blood flow impedance in the second trimester on the later occurrence of preeclampsia Ohkuchi, A.
 2012
 2 3 p. 273-
1 p.
 artikel
258 PP006. The comparison of serum VEGF and sFlt-1 on preeclampsia and eclampsia pregnant woman before and after delivery at Ulin Hospital, Banjarmasin, Indonesia Akbar, A.
 2012
 2 3 p. 243-
1 p.
 artikel
259 PP090. The contribution of podocyturia to the evaluation of ongoing glomerular disorder in pregnant women with kidney graft (preliminary results) Sass, N.
 2012
 2 3 p. 289-
1 p.
 artikel
260 PP052. The course of sFlt-1 and PLGF reflects different progression pattern in early- versus late-onset preeclampsia and HELLP syndrome Schaarschmidt, W.
 2012
 2 3 p. 269-
1 p.
 artikel
261 PP041. The effect of exercise in pregnant women with chronic hypertension and/or previous preeclampsia on blood pressure and heart rate variability Burgos, C.S.G.
 2012
 2 3 p. 263-264
2 p.
 artikel
262 PP096. The effect of preterm placental calcification on uteroplacental blood flow, fetal growth and perinatal outcome in hypertension complicating pregnancy Chen, K.-H.
 2012
 2 3 p. 292-
1 p.
 artikel
263 PP139. The elective prematurity birth and its perinatal effects of syndromes in hypertensive pregnancy Marra, N.B.F.
 2012
 2 3 p. 315-
1 p.
 artikel
264 PP069. The expressions of B7-H1 and B7-H4 co-stimulatory molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy. The expressions of B7-H1 and B7-H4 co-stimulatory moleculeson myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy Darmochwal-Kolarz, D.A.
 2012
 2 3 p. 278-279
2 p.
 artikel
265 PP022 The haemostatic suture (technique of B-Lynch) may be an alternative to control uterine hemorrhage associated with hypertensive disorders Korkes, H.
 2012
 2 3 p. 252-253
2 p.
 artikel
266 PP039. The importance of intentionally considering class 1 HELLP syndrome outcomes versus all other categories of HELLP syndrome or severe preeclampsia Martin Jr., J.N.
 2012
 2 3 p. 262-263
2 p.
 artikel
267 PP179. The influence of prior abortion on rates of gestational hypertension/pre-eclampsia and spontaneous preterm delivery in nulliparous women Clark, K.
 2012
 2 3 p. 337-
1 p.
 artikel
268 PP141. The lipid transporters ABCA1 and ABCG1 are differentially expressed in preeclamptic and IUGR placentas Körner, M.
 2012
 2 3 p. 315-316
2 p.
 artikel
269 PP086. The modern search for possible predictors of preeclampsia in the first trimester of pregnancy (preliminary study) Khodzhaeva, Z.S.
 2012
 2 3 p. 287-
1 p.
 artikel
270 PP111. The preceding features before onset of gestational hypertension and preeclampsia in home blood pressure monitoring: The existence of the inflection point and the rapid increased speed of blood pressure Ohmaru, T.
 2012
 2 3 p. 299-300
2 p.
 artikel
271 PP031. The prevalence of microalbuminuria following preeclampsia Spaan, J.
 2012
 2 3 p. 258-259
2 p.
 artikel
272 PP168. The role of calcium supplementation in prevention endothelial cell activation, and possible relevance to preeclampsia Chen, Q.
 2012
 2 3 p. 330-
1 p.
 artikel
273 PP110. The role of doppler to predict adverse pregnancy outcome in patients with pre-eclampsia Pagani, G.
 2012
 2 3 p. 298-299
2 p.
 artikel
274 PP061. The role of heat shock protein 60 and 70 in early- and late-onset preeclampsia differentiation Peracoli, J.C.
 2012
 2 3 p. 275-
1 p.
 artikel
275 PP173. The role of mean artery blood pressure in the prediction of pre-eclampsia in pregnancies complicated with chronic hypertension Rovida, P.L.
 2012
 2 3 p. 333-334
2 p.
 artikel
276 PP019 The role of renal markers in women with and without preeclampsia: Evaluation of urinary excretion of podocytes and proteins Sass, N.
 2012
 2 3 p. 251-252
2 p.
 artikel
277 PP181. The role of the JAK–STAT pathways and SOCS in preeclampsia Ferreira, D.G.
 2012
 2 3 p. 338-339
2 p.
 artikel
278 PP119. The role of the nuclear factor erythroid 2-related factor 2 (Nrf2) in preeclampsia Kweider, N.
 2012
 2 3 p. 303-304
2 p.
 artikel
279 PP057. The role of uterine artery pulsatility index for prediction of pregnancy outcome, in women affected by pre-eclampsia Gregorini, M.E.
 2012
 2 3 p. 272-273
2 p.
 artikel
280 PP177. The usefulness of gestation-corrected hyperuricemia as a predictor of the development of preeclampsia on subsequent pregnancy Kim, J.
 2012
 2 3 p. 336-
1 p.
 artikel
281 PP174. Timely prediction of maternal complications in pre-eclampsia analysis of the fullPIERS model Akkermans, J.
 2012
 2 3 p. 334-335
2 p.
 artikel
282 PP063. TLR-4 expression and pro-inflammatory cytokine production by peripheral blood monocytes from preeclamptic women Romao, M.
 2012
 2 3 p. 276-
1 p.
 artikel
283 PP028. To assess maternal and neonatal outcomes of women on an antihypertensive agent with gestational hypertension, chronic hypertension or preeclampsia Holcomb, L.
 2012
 2 3 p. 257-
1 p.
 artikel
284 PP078. Total antioxidant capacity in patients with pregnancy induced hypertension: Its relation to maternal and/or perinatal complications Garcia-benavides, L.
 2012
 2 3 p. 282-283
2 p.
 artikel
285 PP165. Treatment approaches for preeclampsia: A sample from a big city of a developing country De Oliveira, L.
 2012
 2 3 p. 328-329
2 p.
 artikel
286 PP124. Trofoblastic invasion: The role of subunits STAT1 and STAT3 Marconato, H.M.F.
 2012
 2 3 p. 306-
1 p.
 artikel
287 PP023. Unexpected random urinary protein: creatinine ratio results – Insightsfrom clinician-laboratory medicine collaboration De Silva, D.A.
 2012
 2 3 p. 253-
1 p.
 artikel
288 PP032. Unique features of long-term cardiovascular phenotype in young women with early-onset pre-eclampsia Lazdam, M.
 2012
 2 3 p. 259-260
2 p.
 artikel
289 PP025. Urinary dipstick proteinuria testing – Does automated strip analysis offer an advantage over visual testing? De Silva, D.A.
 2012
 2 3 p. 255-256
2 p.
 artikel
290 PP001. Variability in MRNA expression of Jmjd6 and FLT-1 variants in normal and preeclamptic human placenta Surmon, L.
 2012
 2 3 p. 240-
1 p.
 artikel
291 PP027. Variation of urinary protein/creatinine ratio during the day in women suspected for preeclampsia Verdonk, K.
 2012
 2 3 p. 257-
1 p.
 artikel
292 Travel Bursary Winners 2012
 2 3 p. vii-viii
nvt p.
 artikel
293 Welcome Message and Committees 2012
 2 3 p. iii-
1 p.
 artikel
                             293 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland